Guardian Pharmacy Service Analyst Price Targets

Wall Street analyst price targets and consensus rating for Guardian Pharmacy Service (GRDN).

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$43Upside to Avg. PT+1.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	Keybanc	Zach Haggerty	Initiate	Overweight	$52
Sep 21, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$47→$51
Aug 7, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$43→$49
Jun 17, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$43→$47
Jun 17, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$42→$47
May 7, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$38→$43
Apr 27, 2026	B of A Securities	Allen Lutz	Initiate	Buy	$42
Apr 13, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$38→$43
Mar 30, 2026	Jefferies	Brian Tanquilut	Initiate	Buy	$44
Mar 12, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$35→$38
Mar 12, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$34→$38
Jan 14, 2026	Stephens & Co.	Scott Fidel	PT Raise	Overweight	$35→$36
Nov 14, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$30→$34
Oct 10, 2025	Oppenheimer	Michael Wiederhorn	Initiate	Outperform	$30
Sep 26, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$28→$30
May 19, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$25→$28
Apr 11, 2025	Truist Securities	David Macdonald	PT Raise	Buy	$24→$25
Nov 15, 2024	Truist Securities	David Macdonald	PT Raise	Buy	$22→$24
Oct 22, 2024	Stephens & Co.	Scott Fidel	Initiate	Overweight	$21
Oct 21, 2024	Truist Securities	David Macdonald	Initiate	Buy	$22

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.

Avi Kapoor

PRO
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52

Keybanc analyst Zach Haggerty initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Overweight rating and announces Price Target of $52.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.

Benzinga Newsdesk

PRO
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $42 to $47.

Benzinga Newsdesk

Guardian Pharmacy Services Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Guardian Pharmacy Service Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

PRO
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

People Also Watch

People Also Watch

Guardian Pharmacy Services Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Guardian Pharmacy Service Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROKeybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52

PROTruist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

PROOppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

PROTruist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

PROB of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

People Also Watch

People Also Watch

PRO
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

PRO
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47